07/10/2026
This article synthesizes known cutaneous adverse effects of immunosuppressive therapies used in solid organ transplant recipients, emphasizing their timing, presentation, and oncologic risk: https://www.jaad.org/article/S0190-9622(26)00492-5/fulltext
It also encourages dermatologists to proactively screen for and manage these toxicities, coordinate with transplant teams, and tailor surveillance based on agent-specific risks.
